- Home
- MFIN vs TVGN Comparison
MFIN vs TVGN Comparison
Compare MFIN & TVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Company Overview
Basic Information| Metric | MFIN | TVGN |
|---|---|---|
| Founded | 1995 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Blank Checks |
| Sector | Finance | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 244.4M | 89.6M |
| IPO Year | 1996 | N/A |
Fundamental Metrics
Financial Performance| Metric | MFIN | TVGN |
|---|---|---|
| Price | $10.15 | $0.36 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $12.00 | $5.00 |
| AVG Volume (30 Days) | 41.6K | ★ 1.5M |
| Earning Date | 10-29-2025 | 11-14-2025 |
| Dividend Yield | ★ 4.72% | N/A |
| EPS Growth | ★ 1.06 | N/A |
| EPS | ★ 1.71 | N/A |
| Revenue | ★ $338,783,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $5.83 | N/A |
| P/E Ratio | $5.95 | ★ N/A |
| Revenue Growth | ★ 15.53 | N/A |
| 52 Week Low | $7.71 | $0.30 |
| 52 Week High | $10.98 | $1.92 |
Technical Indicators
Market Signals| Indicator | MFIN | TVGN |
|---|---|---|
| Relative Strength Index (RSI) | 45.27 | 41.35 |
| Support Level | $10.43 | $0.30 |
| Resistance Level | $10.61 | $0.41 |
| Average True Range (ATR) | 0.24 | 0.03 |
| MACD | -0.06 | 0.00 |
| Stochastic Oscillator | 3.90 | 49.69 |
Price Performance
Historical Comparison MFIN
TVGN
About MFIN Medallion Financial Corp.
Medallion Financial Corp is a finance company that originates and services loans in various industries. The five operating segments are, (1) recreation, (2) home improvement, (3) commercial, (4) taxi medallion, and (5) strategic partnership loans. The company generates maximum revenue from the Recreation segment.
About TVGN Tevogen Bio Holdings Inc.
Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.